Cite
HARVARD Citation
Youssef, J. et al. (2022). The Use of IV Vasoactive Intestinal Peptide (Aviptadil) in Patients With Critical COVID-19 Respiratory Failure: Results of a 60-Day Randomized Controlled Trial*. Critical care medicine. 50 (11), pp. 1545-1554. [Online].